Cited by 1,987Cancer-related Molecular PathwaysCell death mechanisms and regulationPI3K/AKT/mTOR signaling in cancer

The DOI matches its Crossref record; 60 of the 70 references it cites were found in a registry or an index.

The p53 proto-oncogene can act as a suppressor of transformation

Finlay, Cathy A., Hinds, Philip W., Levine, Arnold J.·1989·Cell

Open this paper in CoChat — free account

Abstract

DNA clones of the wild-type p53 proto-oncogene inhibit the ability of E1A plus ras or mutant p53 plus ras-activated oncogenes to transform primary rat embryo fibroblasts. The rare clones of transformed foci that result from E1A plus ras plus wild-type p53 triple transfections all contain the p53 DNA in their genome, but the great majority fail to express the p53 protein. The three cell lines derived from such foci that express p53 all produce mutant p53 proteins with properties similar or identical to transformation-activated p53 proteins. The p53 mutants selected in this fashion (transformation in vitro) resemble the p53 mutants selected in tumors (in vivo). These results suggest that the p53 proto-oncogene can act negatively to block transformation.

Integrity signals

Registry

Crossref · 10.1016/0092-8674(89)90045-7

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,302
A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., & Dryja, T. P. (1986) · Nature · doi:10.1038/323643a0 · Cited by 2,948
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804
Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.
Southern, P. J., & Berg, P. R. (1982) · PubMed · Cited by 2,740
T antigen is bound to a host protein in SY40-transformed cells
Lane, D. P., & Crawford, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,456
Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells
Linzer, D. I. H., & Levine, A. J. (1979) · Cell · doi:10.1016/0092-8674(79)90293-9 · Cited by 1,814
Self-citation
SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene
DeCaprio, J. A., Ludlow, J. W., Figge, J., Shew, J.-Y., Huang, C.-M., Lee, W.-H., Marsilio, E., Paucha, E., & Livingston, D. M. (1988) · Cell · doi:10.1016/0092-8674(88)90559-4 · Cited by 1,459
Human Retinoblastoma Susceptibility Gene: Cloning, Identification, and Sequence
Lee, W., Bookstein, R., Hong, F., Young, L.-J., Shew, J., & Lee, E. Y.-H. P. (1987) · Science · doi:10.1126/science.3823889 · Cited by 1,417
Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product
Whyte, P., Buchkovich, K. J., Horowitz, J. M., Friend, S. H., Raybuck, M., Weinberg, R. A., & Harlow, E. (1988) · Nature · doi:10.1038/334124a0 · Cited by 1,403
Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture
Ruley, H. E. (1983) · Nature · doi:10.1038/304602a0 · Cited by 1,248

Show all 70 references

Sorted by citations

Items 701–800 of 999

Progression toward tumor cell phenotype is enhanced by overexpression of a mutant p53 tumor-suppressor gene isolated from nasopharyngeal carcinoma.
Sun, Y., Nakamura, K., Wendel, E. J., & Colburn, N. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.7.2827 · Cited by 54
Immunohistochemical analysis of p53 protein over-expression in endometrial carcinomas: Inverse correlation with sex steroid receptor status
Koshiyama, M., Konishi, I., Wang, D.-P., Mandai, M., Komatsu, T., Yamamoto, S., Nanbu, K., Naito, M. F., & Mori, T. (1993) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01606889 · Cited by 54
Expression of p21 (waf1/cip1/sdi1), but not p53 protein, is a factor in the survival of patients with advanced gastric carcinoma
Gomyo, Y., Ikeda, M., Osaki, M., Tatebe, S., Tsujitani, S., Ikeguchi, M., Kaibara, N., & Ito, H. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970601)79:11 · Cited by 121
Regulation of apoptosis resistance and ontogeny of age-dependent diseases
Wang, E. (1997) · Experimental Gerontology · doi:10.1016/s0531-5565(96)00156-8 · Cited by 53
Intense P53 Staining is a Valuable Prognostic Indicator for Poor Prognosis in Medulloblastoma/central Nervous System Primitive Neuroectodermal Tumors
Woodburn, R., Azzarelli, B., Montebello, J. F., & Goss, I. E. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1010691330670 · Cited by 53
Serine phosphorylation in the NH2 terminus of p53 facilitates transactivation.
Mayr, G. A., Reed, M. J., Wang, P., Wang, Y., Schweds, J. F., & Tegtmeyer, P. (1995) · PubMed · Cited by 53
Mutational spectrum of the p53 gene in human small-cell lung cancer and relationship to clinicopathological data
Lohmann, D. R., Pütz, B., Reich, U., Böhm, J., Präuer, H. W., & Höfler, H. (1994) · Lung Cancer · doi:10.1016/0169-5002(94)90601-7 · Cited by 53
Mutation of the p53 tumor-suppressor gene is not a feature of endometrial hyperplasias
Kohler, M. F., Nishii, H., Humphrey, P. A., Saski, H., Marks, J. R., Bast, R. C., Clarke‐Pearson, D. L., Boyd, J. A., & Berchuck, A. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(93)90644-x · Cited by 53
Association among p53 gene mutation, nuclear accumulation of the p53 protein and aggressive phenotypes in breast cancer
Tsuda, H., & Hirohashi, S. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570410 · Cited by 53
A conformation hypothesis for the suppressor and promoter functions ofp53in cell growth control and in cancer
Milner, J. (1991) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1991.0100 · Cited by 53
Expression of p53 protein as a prognostic factor in patients With gastric cancer
Victorzon, M., Nordling, S., Haglund, C. H., Lundin, J. E., & Roberts‎, P. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(95)00547-1 · Cited by 53
Involvement of wild-type p53 protein in the cell cycle requires nuclear localization.
Shaulsky, G., Goldfinger, N., Peled, A., & Rotter, V. (1991) · PubMed · Cited by 53
P53 mutations in gastric carcinomas
Seruca, R., David, L., Holm, R., Nesland, J. M., Fangan, B. M., Castedo, S. M. M. J., Sobrinho-Simões, M. A., & Børresen, A.-L. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.149 · Cited by 53
ProtoPred: Advancing Oncological Research Through Identification of Proto-Oncogene Proteins
Malebary, S. J., Khan, R. N., & Khan, Y. D. (2021) · IEEE Access · doi:10.1109/access.2021.3076448 · Cited by 52
Biochemical Studies of the Lagunamides, Potent Cytotoxic Cyclic Depsipeptides from the Marine Cyanobacterium Lyngbya majuscula
Tripathi, A., Fang, W., Leong, D. T., & Tan, L. T. (2012) · Marine Drugs · doi:10.3390/md10051126 · Cited by 52
Expression of Bcl-2, p53 Oncoprotein, and Proliferating Cell Nuclear Antigen in Renal Cell Carcinoma
Sejima, T., & Miyagawa, I. (1999) · European Urology · doi:10.1159/000019855 · Cited by 52
Heat Shock Proteins: Their Role in Urological Tumors
Lebrét, T., William, R., Watson, G. W., & Fitzpatrick, J. M. (2003) · The Journal of Urology · doi:10.1016/s0022-5347(05)64123-7 · Cited by 52
Mutational activation of the c-K-ras gene in human pancreatic carcinoma
Shibata, D. K., Capellá, G., & Perucho, M. (1990) · Baillière s Clinical Gastroenterology · doi:10.1016/0950-3528(90)90044-h · Cited by 52
Demographics, family histories, and psychological characteristics of prostate carcinoma screening participants
Taylor, K. L., DiPlacido, J., Redd, W. H., Faccenda, K., Greer, L., & Perlmutter, A. P. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990315)85:6 · Cited by 50
Gender and Androgen Treatment Influence the Expression of Proto-oncogenes and Apoptotic Factors in Lacrimal and Salivary Tissues of MRL/lprMice
Toda, I., Wickham, L. A., & Sullivan, D. A. (1998) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4466 · Cited by 52
Molecular cloning and expression of a cDNA encoding a protein detected by the ki antibody from an ovarian carcinoma (OVCAR‐3) cell line
Chang, K., & Pastan, I. H. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570117 · Cited by 52
Ultraviolet radiation induction of squamous cell carcinomas in p53 transgenic mice.
Li, G., Ho, V. C., Berean, K. W., & Tron, V. A. (1995) · PubMed · Cited by 52
A t(4;22) in a meningioma points to the localization of a putative tumor-suppressor gene.
Deprez, R. H. L., Groen, N. A., van Biezen, N. A., Hagemeijer, A., van Drunen, E., Koper, J. W., Avezaat, C. J. J., Bootsma, D., & Zwarthoff, E. C. (1991) · Europe PMC (PubMed Central) · Cited by 52
p53 expression and mutations in squamous cell carcinoma of the head and neck: expression correlates with the patients' use of tobacco and alcohol.
Field, J. K., Zoumpourlis, V., Spandidos, D. A., & Jones, A. S. (1994) · PubMed · Cited by 52
Multiple Signaling Pathways Involving ATMPreprint
Kastan, M., Lim, D., KIM, S.-T., Xu, B., & Canman, C. E. (2000) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2000.65.521 · Cited by 53
The SCF Complex Is Essential to Maintain Genome and Chromosome Stability
Thompson, L. L., Rutherford, K. A., Lepage, C. C., & McManus, K. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168544 · Cited by 61
Prognostic value of p53 overexpression in T1G3 bladder tumors treated with bacillus Calmette-Guérin therapy
Peyromaure, M., Weibing, S., Sèbe, P., Verpillat, P., TOUBLANC, M., Dauge, M., BOCCON-GIBOD, L., & Ravery, V. V. (2002) · Urology · doi:10.1016/s0090-4295(01)01551-5 · Cited by 51
Prognostic/Predictive Factors in Breast Cancer
Masood, S. (2005) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2005.08.012 · Cited by 51
Expression of p53, c-erbB-2 and Ki67 in intestinal metaplasia and gastric carcinoma
Zheng, Y. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i3.339 · Cited by 51
Altered p53 gene structure and expression in human epithelial cells after exposure to nickel.
Mæhle, L., Metcalf, R. A., Ryberg, D., Bennett, W. P., Harris, C. C., & Haugen, A. (1992) · PubMed · Cited by 51
Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder.
Shiina, H., Igawa, M., Urakami, S., Honda, S., Shirakawa, H., & Ishibe, T. (1996) · Journal of Clinical Pathology · doi:10.1136/jcp.49.5.395 · Cited by 51
Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p53 expression, DNA flow cytometry, and muscle specific actins.
Amada, S., Nakano, H., & Tsuneyoshi, M. (1995) · PubMed · Cited by 51
Aggressive Medulloblastoma With High-Level N-myc Amplification
Tomlinson, F. H., Jenkins, R. B., Scheithauer, B. W., Keelan, P. A., Ritland, S., Parisi, J. E., Cunningham, J. M., & Olsen, K. D. (1994) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)62221-6 · Cited by 51
p53-Oriented cancer therapies: Current progress
Gallagher, W. M., & Brown, R. E. (1999) · Annals of Oncology · doi:10.1023/a:1008368500557 · Cited by 51
Env‐derived gp55 gene of Friend spleen focus‐forming virus specifically induces neoplastic proliferation of erythroid progenitor cells.
Aizawa, S., Suda, Y., Furuta, Y., Yagi, T., Takeda, N., Watanabe, N., Nagayoshi, M., & Ikawa, Y. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07379.x · Cited by 52
Deletion Mapping of Chromosome 1p and 22q in Pheochromocytoma
Shin, E., Fujita, S., Takami, K., Kurahashi, H., Kurita, Y., Kobayashi, T., Mori, T., Nishisho, I., & Takai, S. (1993) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1993.tb00150.x · Cited by 51
Retroviruses and Their Role in Cancer
Fan, H. (1994) · Springer eBooks · doi:10.1007/978-1-4899-1730-0_7 · Cited by 50
Perturbation in connexin 43 and connexin 26 gap-junction expression in mouse skin hyperplasia and neoplasia
Sawey, M. J., Goldschmidt, M. H., Risek, B., Gilula, N. B., & Lo, C. W. (1996) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199610)17:2 · Cited by 79
p53 expression in myeloid cells of myelodysplastic syndromes. Association with evolution of overt leukemia.
Kitagawa, M., Yoshida, S., Kuwata, T., Tanizawa, T., & Kamiyama, R. (1994) · PubMed Central · Cited by 50
SV40 immortalizes myogenic cells: DNA synthesis and mitosis in differentiating myotubes
Lujvidin, S., Fuchs, O., Nudel, U., & Yaffe, D. (1990) · Differentiation · doi:10.1111/j.1432-0436.1990.tb00446.x · Cited by 50
Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: Comparison with dna ploidy
Nakopoulou, L., Constantinides, C. A., Papandropoulos, J., Theodoropoulos, G. E., Τζώνου, Α., Giannopoulos, A., Zervas, A., & Dimopoulos, C. (1995) · Urology · doi:10.1016/s0090-4295(99)80216-7 · Cited by 50
Characterization of a frequent polymorphism in the coding sequence of the Tp53 gene in colonic cancer patients and a control population
Olschwang, S., Laurent‐Puig, P., Vassal, A., Salmon, R.-J., & Thomas, G. D. (1991) · Human Genetics · doi:10.1007/bf00201836 · Cited by 50
Relationship between TATA-binding protein and herpes simplex virus type 1 ICP4 DNA-binding sites in complex formation and repression of transcription
Kuddus, R., Gu, B., & DeLuca, N. A. (1995) · Journal of Virology · doi:10.1128/jvi.69.9.5568-5575.1995 · Cited by 50
Transfection of Rat Embryo Cells with Mutant p53 Increases the Intrinsic Radiation Resistance
Pardo, F. S., Su, M., Borek, C. G., Preffer, F. I., Dombkowski, D., Gerweck, L. E., & Schmidt, E. V. (1994) · Radiation Research · doi:10.2307/3578901 · Cited by 50
p53: DNA damage, DNA repair, and apoptosis
Götz, C., & Montenarh, M. (1995) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/bfb0048265 · Cited by 50
SV40 early region oncoproteins and human cell transformation.
Chen, W., & Hahn, W. C. (2003) · PubMed · doi:10.14670/hh-18.541 · Cited by 49
Novel 1,2,4-triazole derivatives as apoptotic inducers targeting p53: Synthesis and antiproliferative activity
Gomaa, H. A. M., El-Sherief, H. A. M., Hussein, S., Gouda, A. M., Salem, O. I. A., Alharbi, K. S., Hayallah, A. M., & Youssif, B. G. M. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104369 · Cited by 49
An Update on MDMX and Dual MDM2/X Inhibitors
Espadinha, M., Barcherini, V., Lopes, E. A., & Santos, M. M. M. (2018) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026618666180604080119 · Cited by 49
Genotoxic effects of BnSP-6, a Lys-49 phospholipase A2 (PLA2) homologue from Bothrops pauloensis snake venom, on MDA-MB-231 breast cancer cells
Silva, M. A., Lopes, D. S., Teixeira, S. C., Gimenes, S. N. C., Azevedo, F. V. P. D. V., Polloni, L., Borges, B. C., da Silva, M. S., Barbosa, M. J., Júnior, R. J. D. O., et al. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.06.082 · Cited by 49
Variation of ER status between primary and metastatic breast cancer and relationship to p53 expression ☆ ☆This study was supported by the National Natural Science Foundation of China (No. 39870753) and Changhai Hospital ‘123’ Project.
Zheng, W., Lu, J., Zheng, J., Hu, F.-X., & Ni, C.-R. (2001) · Steroids · doi:10.1016/s0039-128x(01)00121-0 · Cited by 49
Inactivation of the Quinone Oxidoreductases NQO1 and NQO2 Strongly Elevates the Incidence and Multiplicity of Chemically Induced Skin Tumors
Shen, J., Barrios, R. J., & Jaiswal, A. K. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2938 · Cited by 50
Retracted
Discrimination of DNA Binding Sites by Mutant p53 Proteins
Thukral, S. K., Lu, Y., Blain, G. C., Harvey, T. S., & Jacobsen, V. L. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.9.5196 · Cited by 48
Characterization of intestinal alkaline phosphatase expression and the tumorigenic potential of gamma-irradiated HeLa x fibroblast cell hybrids.
Mendonca, M. S., Antoniono, R. J., Latham, K. M., Stanbridge, E. J., & Redpath, J. L. (1991) · PubMed · Cited by 49
The dominating effect of mutant p53
Hann, B. C., & Lane, D. P. (1995) · Nature Genetics · doi:10.1038/ng0395-221 · Cited by 49
Rate-limiting steps: The genetics of pediatric cancers
Haber, D. A., & Housman, D. E. (1991) · Cell · doi:10.1016/0092-8674(91)90200-i · Cited by 49
Synthesis and Biological Evaluation of Indole-2-Carboxamides with Potent Apoptotic Antiproliferative Activity as EGFR/CDK2 Dual Inhibitors
Al-Wahaibi, L. H., Mostafa, Y. A., Abdelrahman, M. H., El‐Bahrawy, A. H., Trembleau, L., & Youssif, B. G. M. (2022) · Pharmaceuticals · doi:10.3390/ph15081006 · Cited by 48
p53: Pro-aging or pro-longevity?
de Keizer, P. L. J., Laberge, R.-M., & Campisi, J. (2010) · Aging · doi:10.18632/aging.100178 · Cited by 48
Molecular biology of transitional cell carcinoma
Al‐Sukhun, S., & Hussain, M. (2003) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(03)00081-7 · Cited by 48
Biological and Molecular Properties of Densoviruses and Their Use in Protein Expression and Biological Control
Bergoin, M., & Tijssen, P. (1998) · Springer eBooks · doi:10.1007/978-1-4615-5341-0_6 · Cited by 48
p53 expression status is associated with cancer-specific survival in stage III and high-risk stage II colorectal cancer patients treated with oxaliplatin-based adjuvant chemotherapy
Oh, H. J., Bae, J. M., Wen, X., Jung, S., Kim, Y.-H., Kim, K. J., Cho, N., Kim, J. H., Han, S., Kim, T., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0429-2 · Cited by 45
MDM2 overexpression is associated with short survival in adults with medulloblastoma
Giordana, M. T., Duó, D., Gasverde, S., Trevisan, E., Boghi, A., Morra, I., Pradotto, L., Mauro, A., & Chiò, A. (2002) · Neuro-Oncology · doi:10.1093/neuonc/4.2.115 · Cited by 48
Transactivation of the p53 oncogene by E1a gene products
Braithwaite, A. W., Nelson, C. C., Skulimowski, A., McGovern, J., Pigott, D., & Jenkins, J. R. (1990) · Virology · doi:10.1016/0042-6822(90)90525-v · Cited by 48
Variable selection and multivariate methods for the identification of microorganisms by flow cytometry
Davey, H. M., Jones, A., Shaw, A. D., & Kell, D. B. (1999) · Cytometry · doi:10.1002/(sici)1097-0320(19990201)35:2 · Cited by 56
p53 expression and K-ras mutation in colorectal adenomas.
Scott, N., Bell, S. M., Sagar, P. M., Blair, G. E., Dixon, M. F., & Quirke, P. (1993) · Gut · doi:10.1136/gut.34.5.621 · Cited by 48
Increased expression and mutation of p53 in choroidal melanoma
Tobal, K., Warren, W., Cooper, C., McCartney, A. C. E., Hungerford, J. L., & Lightman, S. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.382 · Cited by 48
Clear cell carcinoma of the endometrium: Prognosis and metastatic pattern
Abeler, V. M., Vergote, I. B., Zzrstad, K. E. K., & Trope, C. G. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19961015)78:8 · Cited by 144
Induction of 18A2/mts1 Gene Expression and Its Effects on Metastasis and Cell Cycle Control
Parker, C., WHITTAKER, P. A., Usmani, B. A., Lakshmi, M. S., & Sherbet, G. V. (1994) · DNA and Cell Biology · doi:10.1089/dna.1994.13.1021 · Cited by 48
Relationship of eukaryotic DNA replication to committed gene expression: general theory for gene control
Villarreal, L. P. (1991) · Microbiological Reviews · doi:10.1128/mmbr.55.3.512-542.1991 · Cited by 48
Insulin sparing action of Adenovirus 36 and its E4orf1 protein
Dhurandhar, N. V. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.09.006 · Cited by 48
Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: Studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181)
Estrov, Z. E., Talpaz, M., Zipf, T. F., Kantarjian, H. M., Ku, S., Ouspenskaia, M. V., Hirsch‐Ginsberg, C., Huh, Y. O., Yee, G., & Kurzrock, R. (1996) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199603)166:3 · Cited by 30
Knockdown of p53 levels in human keratinocytes accelerates Mcl-1 and Bcl-xL reduction thereby enhancing UV-light induced apoptosis
Chaturvedi, V., Sitailo, L. A., Qin, J., Bodner, B. K., Denning, M. F., Curry, J. L., Zhang, W., Brash, D. E., & Nickoloff, B. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208650 · Cited by 46
Expression of retinoblastoma gene product and p53 protein in bladder carcinoma: correlation with Ki67 index
Wright, C., Thomas, D., Mellon, K., Neal, D. E., & Horne, C. H. W. (1995) · British Journal of Urology · doi:10.1111/j.1464-410x.1995.tb07306.x · Cited by 47
Expression of cell-cycle–associated proteins pRB2/p130 and p27kip1 in vulvar squamous cell carcinomas
Zamparelli, A., Masciullo, V., Bovicelli, A., Santini, D., Ferrandina, G., Minimo, C., Terzano, P., Costa, S., Cinti, C., Ceccarelli, C., et al. (2001) · Human Pathology · doi:10.1053/hupa.2001.20371 · Cited by 47
Simian virus 40 large T antigen contains two independent activities that cooperate with a ras oncogene to transform rat embryo fibroblasts
Cavender, J. F., Conn, A. R., Epler, M. J., Lacko, H. A., & Tevethia, M. J. (1995) · Journal of Virology · doi:10.1128/jvi.69.2.923-934.1995 · Cited by 48
TP53 Mutation in Acute Myeloid Leukemia: An Old Foe Revisited
Shin, D.-Y. (2023) · Cancers · doi:10.3390/cancers15194816 · Cited by 46
Immunohistochemical detection of p53 and PCNA in ameloblastoma and adenomatoid odontogenic tumor
Salehinejad, J., Zare-Mahmoodabadi, R., Saghafi, S., Jafarian, A. H., Ghazi, N., Rajaei, A.-R., & Marouzi, P. (2011) · Journal of Oral Science · doi:10.2334/josnusd.53.213 · Cited by 46
DNA damage signalling recruits RREB-1 to the p53 tumour suppressor promoter
Liu, H., Hew, H. C., Lu, Z., Yamaguchi, T., Miki, Y., & Yoshida, K. (2009) · Biochemical Journal · doi:10.1042/bj20090342 · Cited by 47
p53, proto-oncogene and rheumatoid arthritis
Sun, Y., & Cheung, H. S. (2002) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2002.31550 · Cited by 45
Decelerating growth and human breast cancer
Spratt, J. A., von Fournier, D., Spratt, J. S., & Weber, E. (1993) · Cancer · doi:10.1002/1097-0142(19930315)71:6 · Cited by 189
Tumor suppressor genes: Possible functions in the negative regulation of cell proliferation
Boyd, J. A., & Barrett, J. C. (1990) · Molecular Carcinogenesis · doi:10.1002/mc.2940030603 · Cited by 46
Transforming Activity of Bovine and Human Papillomaviruses in Cultured Cells
DiMaio, D. (1991) · Advances in cancer research · doi:10.1016/s0065-230x(08)60480-7 · Cited by 46
New perspective on targeting the tumor suppressor p53 pathway in the tumor microenvironment to enhance the efficacy of immunotherapy
Guo, G., & Cui, Y. R. (2015) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-015-0053-5 · Cited by 47
Expression and Role of p53 in the Retina
Vuong, L., Conley, S. M., & Al‐Ubaidi, M. R. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8909 · Cited by 45
Combining Oncolytic Virotherapy with p53 Tumor Suppressor Gene Therapy
Bressy, C., Hastie, E. L., & Grdzelishvili, V. Z. (2017) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2017.03.002 · Cited by 50
Radiogenomics in renal cell carcinoma
Alessandrino, F., Shinagare, A. B., Bossé, D., Choueiri, T. K., & Krajewski, K. M. (2018) · Abdominal Radiology · doi:10.1007/s00261-018-1624-y · Cited by 46
Extracellular Vesicles: Messengers of p53 in Tumor–Stroma Communication and Cancer Metastasis
Pavlakis, E., Neumann, M. M., & Stiewe, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249648 · Cited by 45
P53 Protein Expression in Eccrine Poroma and Porocarcinoma
Akalın, T., Şen, S., Yücetürk, A., & Kandiloğlu, G. (2001) · American Journal of Dermatopathology · doi:10.1097/00000372-200110000-00003 · Cited by 45
Facilitation of adenoviral wild-type p53-induced apoptotic cell death by overexpression of p33ING1 in T.Tn human esophageal carcinoma cells
Shimada, H., Liu, T., Ochiai, T., Shimizu, T., Haupt, Y., Hamada, H., Abe, T., Oka, M., Takiguchi, M., & Hiwasa, T. (2002) · Oncogene · doi:10.1038/sj.onc.1205176 · Cited by 45
DISTINCTIVE ADHESION PATHWAYS ARE INVOLVED IN EPITHELIOTROPIC PROCESSES AT DIFFERENT SITES
Jaspars, L. H., Beljaards, R. C., Bonnet, P., Willemze, R., & Meijer, C. J. L. M. (1996) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199604)178:4 · Cited by 24
Loss of heterozygosity on the long arm of chromosome 22 in pheochromocytoma
Tanaka, N., Nishisho, I., Yamamoto, M. P., Miya, A., Shin, E., Karakawa, K., Fujita, S., Kobayashi, T., Rouleau, G. A., Mori, T., et al. (1992) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870050416 · Cited by 45
Involvement of Heat‐Shock Protein 70 and P53 Proteins in Attenuation of UVC‐lnduced Apoptosis by Thermal Stress in Hepatocellular Carcinoma Cells
Chen, Y., Lin‐Shiau, S., & Lin, J. (1999) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1999.tb01952.x · Cited by 45
Functional characterization of p53 molecules expressed in human squamous cell carcinomas of the head and neck
Yeudall, W. A., Jakus, J., Ensley, J. F., & Robbins, K. C. (1997) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199702)18:2 · Cited by 45
Radiation induced G1-block and p53 status in six human cell lines
Zölzer, F., Hillebrandt, S., & Streffer, C. (1995) · Radiotherapy and Oncology · doi:10.1016/0167-8140(95)01618-q · Cited by 45
An intron binding protein is required for transformation ability of p53
Beenken, S. W., Karsenty, G., Raycroft, L., & Lozano, G. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.17.4747 · Cited by 45
Identification of a p53 binding site in the human retinoblastoma susceptibility gene promoter.
Osifchin, N. E., Jiang, D., Ohtani‐Fujita, N., Fujita, T., Carroza, M., Kim, S. J., Sakai, T., & Robbins, P. D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37383-0 · Cited by 44
Activation of the human immunodeficiency virus type 1 long terminal repeat by transforming mutants of human p53
Subler, M. A., Martin, D. W., & Deb, S. (1994) · Journal of Virology · doi:10.1128/jvi.68.1.103-110.1994 · Cited by 45
Metastasis-Associated mts1 Gene Expression Correlates with Increased p53 Detection in the B16 Murine Melanoma
Parker, C., Lakshmi, M. S., Piura, B., & Sherbet, G. V. (1994) · DNA and Cell Biology · doi:10.1089/dna.1994.13.343 · Cited by 45
p53 Expression in Human Breast Cancer
Harris, A. L. (1992) · Advances in cancer research · doi:10.1016/s0065-230x(08)60303-6 · Cited by 45
Loss of Expression of the p16 Tumor Suppressor Gene Is More Frequent in Advanced Ovarian Cancers Lacking p53 Mutations
Havrilesky, L. J., Secord, A. A., Whitaker, R. S., Marks, J. R., & Berchuck, A. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2001.6464 · Cited by 44
Current pathogenetic and molecular concepts in viral liver carcinogenesis
Schirmacher, P., Rogler, C. E., & Dienes, H. P. (1993) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02899246 · Cited by 44

Authors: Finlay, C. A., Hinds, P. W., & Levine, A. J.
Affiliations: Princeton University (US)
ORCID: Hinds, Philip W.
Levine, Arnold J.
Venue: Cell
Publisher: Elsevier BV
Published: 1989-06
Volume: 57
Issue: 7
Pages: 1083-1093
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/0092-8674(89)90045-7
OpenAlex: W2163565167
Cited by: 1,987
References: 70
Citations by year: 2026: 14 · 2025: 12 · 2024: 25 · 2023: 27 · 2022: 20 · 2021: 34 · 2020: 37 · 2019: 31 · 2018: 29 · 2017: 29 · 2016: 28 · 2015: 12 · 2014: 28 · 2013: 26 · 2012: 38
FWCI: 79.38
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Cell (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (P01CA041086, P01-CA41086-03)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords: tumor suppressor, oncogenic transformation, adenovirus E1A, oncogenic Ras, mutant p53, p53 expression, rat embryo fibroblasts, transformed foci, tumor suppressor function
MeSH terms: Animals, Antigens, Polyomavirus Transforming, Cell Line, Cell Transformation, Neoplastic, Cells, Cultured, Gene Expression Regulation, Neoplasm Proteins, Oncogene Proteins, Viral, Phosphoproteins, Proto-Oncogene Proteins, Genes, ras, Transfection, Tumor Suppressor Protein p53, Adenovirus Early Proteins, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The p53 proto-oncogene can act as a suppressor of transformation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks